Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Purdue Scientists Probe How Two Groups of Viruses Cause Disease

By R&D Editors | December 14, 2009

Purdue Virus Research
Richard Kuhn, top left, head of the Department of Biological Sciences, Michael Rossmann, right standing, the Hanley Distinguished Professor of Biological Sciences, and Wen Jiang, an assistant professor in the Department of Biological Sciences.
 

Purdue University is leading a team of researchers in a federally funded effort aimed ultimately at developing better vaccines and antiviral drugs against two types of disease-causing viruses by learning critical details about their life cycles.

The viruses also pose a potential homeland security threat because they have been used to make biological weapons, said Richard Kuhn, a professor and head of the Department of Biological Sciences at Purdue.

“Viruses within these two groups pose significant risks to large segments of the population, and methods for controlling infection and disease are few,” he said. “These are really important human diseases.” One group, called flaviviruses, includes West Nile and dengue. The other group, called alphaviruses, includes eastern equine encephalitis and chikungunya.

“Dengue infects more than 50 million people annually, killing about 24,000 each year, primarily in tropical regions,” Kuhn said.

Both types of viruses are transmitted by mosquitoes and sometimes ticks.

“Although these viruses are now mostly restricted to the tropics, as population density increases in cities and there is a greater global movement of people, there is the fear that these viruses are going to gain a greater geographical range,” Kuhn said. “There also is the possibility of terrorists using weapons made from these viruses, so a better understanding of their life cycles could lead to ways to defend against attacks.”

The work is funded with a two-year $4 million American Recovery and Reinvestment Act grant through the National Institutes of Health’s National Institute of Allergy and Infectious Diseases.

The researchers will use advanced imaging technologies, including cryoelectron microscopy and X-ray crystallography, along with techniques in biochemistry, molecular biology, and genetics, to uncover critical structural details about the viruses.

Both types of viruses have a two-layer outer protein-and-lipid membrane envelope and a genome of RNA, or ribonucleic acid. In alphaviruses, the heads of key proteins protrude outward like spikes, with the tails extending into the virus. The proteins in the flaviviruses lie flat on the surface of the virus’ outer shell, which resembles a golf ball’s bumpy shape.

“The current understanding of alphavirus and flavivirus life cycles at the molecular level is incomplete because we lack a structural foundation for the viral and host proteins involved in RNA replication, how this genome is packaged, and how the virus is assembled inside the host cells,” Kuhn said. “We are interested in their life cycles.

“What do they look like? How do they get into cells? What happens once they do? Then, how do they assemble themselves and exit the host cells?”

Researchers also will probe how antibodies bind to the viruses.

“Using structural information, we can figure out how the antibodies work and which sites they specifically bind to on the outside of the viruses, and those findings may lead to better vaccines and antiviral drugs and a better understanding of how the viruses infect host cells,” Kuhn said.

Release date:
Source: Purdue University 

Related Articles Read More >

Scientists discover compounds that could help fight any virus
Festo pumps 8% of revenue into R&D, driving miniaturized automation for life sciences
New NVIDIA AI achieves over 75% ‘co-designability’ in atom-level protein generation, doubling the success rate of prior methods
AI system found over 300 potential antibiotic compounds in snake and spider venom
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE